Literature DB >> 12091043

Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII.

Lars M Asmis1, Irmela Sulzer, Miha Furlan, Bernhard Lämmle.   

Abstract

Hereditary plasma prekallikrein (PK) deficiency was diagnosed in a 71-year-old man with an 8-year history of osteomyelofibrosis. PK deficiency was suspected in view of a severely prolonged activated partial thromboplastin time (aPTT) that nearly normalized following prolonged preincubation (10 min) of patient plasma with kaolin-inosithin reagent. Hereditary PK deficiency was demonstrated by very low PK values in the propositus (PK clotting activity 5%, PK amidolytic activity 5%, PK antigen 2% of normal plasma, respectively) and half normal PK values in his children. Normalization of a severely increased aPTT (>120 s) after prolonged preincubation with aPTT reagent occurred in plasma deficient in PK but not in plasma deficient in factor XII (FXII), high-molecular-weight kininogen (HK), factor XI (FXI), factor IX, factor VIII, Passovoy trait plasma or plasma containing lupus anticoagulant. Autoactivation of FXII in PK-deficient plasma in the presence of kaolin paralleled the normalization of aPTT. Addition of OT-2, a monoclonal antibody inhibiting activated FXII, prevented the normalization of aPTT. We conclude that the normalization of a severely prolonged aPTT upon increased preincubation time (PIT), characteristic of PK deficiency, is due to FXII autoactivation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091043     DOI: 10.1016/s0049-3848(02)00045-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

Review 1.  Human plasma kallikrein-kinin system: physiological and biochemical parameters.

Authors:  J W Bryant; Z Shariat-Madar
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-07

2.  A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.

Authors:  Ivy Riano; Klaorat Prasongdee
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

3.  Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein.

Authors:  Jia Liu; Ben-Bo Gao; Allen C Clermont; Price Blair; Tamie J Chilcote; Sukanto Sinha; Robert Flaumenhaft; Edward P Feener
Journal:  Nat Med       Date:  2011-01-23       Impact factor: 53.440

Review 4.  The Effects of the Contact Activation System on Hemorrhage.

Authors:  Fabrício Simão; Edward P Feener
Journal:  Front Med (Lausanne)       Date:  2017-07-31

5.  Diagnostic Pearls and Clinical Implications of Prekallikrein Deficiency.

Authors:  Hassaan Yasin; Muhammad Omer Jamil; Lance A Williams Iii
Journal:  Cureus       Date:  2020-05-29

6.  The First Case of Congenital Prekallikrein Deficiency in Korea With a Novel Pathogenic Variant (c.1198G>T).

Authors:  Sohee Ryu; Ja Yoon Gu; Kyung Taek Hong; Doo Hee Han; Hyun Kyung Kim
Journal:  Ann Lab Med       Date:  2019-03       Impact factor: 3.464

7.  The First Korean Case of High-Molecular-Weight Kininogen Deficiency, With a Novel Variant, c.488delG, in the KNG1 Gene.

Authors:  Dajeong Jeong; Ja Yoon Goo; Hyun Kyung Kim; So Young Chong; Myung Seo Kang
Journal:  Ann Lab Med       Date:  2020-05       Impact factor: 3.464

8.  Prekallikrein deficiency presenting as recurrent cerebrovascular accident: case report and review of the literature.

Authors:  Esteban Uribe Bojanini; Arturo Loaiza-Bonilla; Agustin Pimentel
Journal:  Case Rep Hematol       Date:  2012-08-16

9.  Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI.

Authors:  Katherine J Kearney; Juliet Butler; Olga M Posada; Clare Wilson; Samantha Heal; Majid Ali; Lewis Hardy; Josefin Ahnström; David Gailani; Richard Foster; Emma Hethershaw; Colin Longstaff; Helen Philippou
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-19       Impact factor: 12.779

10.  A novel murine in vivo model for acute hereditary angioedema attacks.

Authors:  Sujata Bupp; Matthew Whittaker; Mari Lehtimaki; JuMe Park; Jessica Dement-Brown; Zhao-Hua Zhou; Steven Kozlowski
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.